Issue 34 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

19

No.

34

September 03, 1993Sep 03, 1993

Free

DOWNLOAD THE PDF

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

NCI Clarifies IRPG Application Receipt, Funding Policies

Recent Issues

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026